257 related articles for article (PubMed ID: 23200208)
21. [Evaluation of external quality assurance in accordance with sect. 137 SGB V at the Carl Gustav Carus university hospital in Dresden].
Petzold T; Steinwitz A; Schmitt J; Eberlein-Gonska M
Z Evid Fortbild Qual Gesundhwes; 2013; 107(8):541-7. PubMed ID: 24290668
[TBL] [Abstract][Full Text] [Related]
22. Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: a decade experience of a universal health insurance program.
Cheng JS; Tsai WC; Lin CL; Chen L; Lang HC; Hsieh HM; Shin SJ; Chen T; Huang CT; Hsu CC
Med Care; 2015 Feb; 53(2):116-24. PubMed ID: 25517075
[TBL] [Abstract][Full Text] [Related]
23. [The German program for disease management guidelines. Results and perspectives].
Ollenschläger G; Kopp I
Med Klin (Munich); 2007 May; 102(5):383-7. PubMed ID: 17497089
[TBL] [Abstract][Full Text] [Related]
24. Quality of care for patients with type 2 diabetes mellitus in the Netherlands and the United States: a comparison of two quality improvement programs.
Valk GD; Renders CM; Kriegsman DM; Newton KM; Twisk JW; van Eijk JT; van der Wal G; Wagner EH
Health Serv Res; 2004 Aug; 39(4 Pt 1):709-25. PubMed ID: 15230924
[TBL] [Abstract][Full Text] [Related]
25. [BOT with insulin glargine versus BOT with insulin detemir: comparison of treatment costs in type 2 diabetes based on the results of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study from the German Statutory Health Insurance perspective].
Schädlich PK; Koltermann KC; Dippel FW; Hagenmeyer EG; Häussler B
MMW Fortschr Med; 2010 Oct; 152 Suppl 3():89-95. PubMed ID: 21595152
[No Abstract] [Full Text] [Related]
26. [Costs of type 2 diabetes in Germany. Results of the CODE-2 study].
Liebl A; Neiss A; Spannheimer A; Reitberger U; Wagner T; Görtz A
Dtsch Med Wochenschr; 2001 May; 126(20):585-9. PubMed ID: 11402924
[TBL] [Abstract][Full Text] [Related]
27. German diabetes management programs improve quality of care and curb costs.
Stock S; Drabik A; Büscher G; Graf C; Ullrich W; Gerber A; Lauterbach KW; Lüngen M
Health Aff (Millwood); 2010 Dec; 29(12):2197-205. PubMed ID: 21134920
[TBL] [Abstract][Full Text] [Related]
28. Disease management programs in type 2 diabetes: quality of care.
Berthold HK; Bestehorn KP; Jannowitz C; Krone W; Gouni-Berthold I
Am J Manag Care; 2011 Jun; 17(6):393-403. PubMed ID: 21756010
[TBL] [Abstract][Full Text] [Related]
29. [Diversity in spite of standards: the special features of NDGMs].
Meyerrose B; Conrad S; Fishman L; Langer T; Weikert B; Weinbrenner S
Z Evid Fortbild Qual Gesundhwes; 2010; 104(7):540-6. PubMed ID: 21095606
[TBL] [Abstract][Full Text] [Related]
30. German diabetes disease management programs are appropriate for restructuring care according to the chronic care model: an evaluation with the patient assessment of chronic illness care instrument.
Szecsenyi J; Rosemann T; Joos S; Peters-Klimm F; Miksch A
Diabetes Care; 2008 Jun; 31(6):1150-4. PubMed ID: 18299443
[TBL] [Abstract][Full Text] [Related]
31. [The German program for disease management guidelines. Background, methods, and development process].
Ollenschläger G; Kopp I; Lelgemann M; Sänger S; Heymans L; Thole H; Trapp H; Lorenz W; Selbmann HK; Encke A
Med Klin (Munich); 2006 Oct; 101(10):840-5. PubMed ID: 17039328
[TBL] [Abstract][Full Text] [Related]
32. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
von Ferber L; Köster I; Hauner H
Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
[TBL] [Abstract][Full Text] [Related]
33. [A pilot study to evaluate the DMP for coronary heart disease - Development of a methodology and first results].
Schulte T; Mund M; Hofmann L; Pimperl A; Dittmann B; Hildebrandt H
Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():54-9. PubMed ID: 26875036
[TBL] [Abstract][Full Text] [Related]
34. Practice-based interventions to improve health care for Latinos with diabetes.
Cleghorn GD; Nguyen M; Roberts B; Duran G; Tellez T; Alecon M
Ethn Dis; 2004; 14(3 Suppl 1):S117-21. PubMed ID: 15682780
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of a quality improvement collaborative focusing on patients with diabetes.
Schouten LM; Niessen LW; van de Pas JW; Grol RP; Hulscher ME
Med Care; 2010 Oct; 48(10):884-91. PubMed ID: 20808258
[TBL] [Abstract][Full Text] [Related]
36. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy and cost-effectiveness of smoking cessation courses in the statutory health insurance: a review].
Rasch A; Greiner W
Gesundheitswesen; 2009 Nov; 71(11):732-8. PubMed ID: 19492280
[TBL] [Abstract][Full Text] [Related]
38. [Patient education and treatment documentation - Law to Improve the Rights of Patients].
Meltendorf G; Meltendorf C
Laryngorhinootologie; 2013 Jul; 92(7):482-90; quiz 491-2. PubMed ID: 23824480
[TBL] [Abstract][Full Text] [Related]
39. [Implementing integrated health care--current state and progress].
Stamm J
Z Kardiol; 2005; 94 Suppl 4():IV/4-6. PubMed ID: 16416063
[TBL] [Abstract][Full Text] [Related]
40. [Inpatient medical rehabilitation in diabetes mellitus in light of evidence based practice guidelines: an evaluation on the basis of BfA routine data].
Ganten JU; Raspe HH
Rehabilitation (Stuttg); 2003 Apr; 42(2):94-108. PubMed ID: 12701002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
